Ressources - Pentabase

Phone: +45 36 96 94 96 Mail: info@pentabase.com

4.2 - Very good

Support
FAQ
Distributors
Ressources

English
- Danish

Book Test
COVID-19
Products
Contact

Services
- SNP Genotyping Services
- Real-Time PCR Assay Development

About
- About Us
- Meet the team
- Career
- News
- Sponsorship

Ordering
Support
Privacy Policy
Ressources

Latest news

gfd3e2630d0e4f94d61a53c3daadd06bc57d71636a055985e07c9864006147ac4ff26ce826bea63a562eb620f7999d808_1920

Tuesday 16. Feb 2021 by admin_pentabase

Can we rely on the Rapid test? 

g9edbb8c842d241923e239deca91515056df5dc2ebef3461ca3fce2cba000ce3af7d57cb52df923a290bfe409d48a7e17_1920

Tuesday 16. Feb 2021 by admin_pentabase

Get Tested with Pentabase and avoid 10-day isolation

Support
FAQ
Distributors
Ressources

English
- Danish

No products in the cart.

Menu

Ressources

Download Center

Inspection Report

Inspection Report (Styrelsen for Patientsikkerhed)

Product information

PentaBase Technology Brochure

SensiScreen^® Brochure

PlentiPlex™ Mastocytosis Brochure

PlentiPlex™ MSI Brochure

PlentiPlex™ MYD88 Brochure

PlentiPlex™ Genotyping Brochure

MicroSight® MSI Brochure

Instructions for use

CoviDetect™ FAST

CoviDetect™ Variations

CoviDetect™ 4-Plex

SensiScreen^® Liquid IFU

SensiScreen^® FFPE IFU

PlentiPlex™ Mastocytosis RUO IFU

PlentiPlex™ Mastocytosis CE IVD IFU

PlentiPlex™ MSI

PlentiPlex™ MYD88

Quick Guides

SensiScreen^® Liquid Ready-to-use

SensiScreen^® Liquid Dispense Ready

SensiScreen^® FFPE Ready-to-use

SensiScreen^® FFPE Dispense Ready

PlentiPlex™ Mastocytosis Ready-to-use RUO

PlentiPlex™ Mastocytosis Ready-to-use CE IVD

PlentiPlex™ Mastocytosis Dispense Ready RUO

PlentiPlex™ Mastocytosis Dispense Ready CE IVD

PlentiPlex™ MSI Ready-to-use

PlentiPlex™ MYD88 Dispense Ready

PlentiPlex™ MYD88 Ready-to-use

References - BaseBlocker™

Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia, Baer et al. 2017, Leukemia 31, 1355–1362

References PentAdapters

Integrative Genomics Outlines a Biphasic Glucose
Response and a ChREBP-RORg Axis Regulating Proliferation in beta Cells, Schmidt et al. 2016, Cell Rep. 2016 Aug 30;16(9):2359-72

Circulating tumor DNA shows variable clonal response of breast cancer during neoadjuvant chemotherapy, Kim et al. 2017, Oncotarget. Sep 23;8(49):86423-86434

Characterization of background noise in capture-based targeted sequencing data, PArk et al. 2017, Genome Biol. Jul 21;18(1):136

Utility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patients, Park et al. 2018, Sci Rep. Aug 2;8(1):11631

Accurate Recycling of Parental Histones Reproduces the Histone Modification Landscape during DNA Replication, Reverón-Gómez et al. 2018, Mol Cell. Oct 18;72(2):239-249.e5

Genetic and epigenetic variation in 5S ribosomal RNA genes reveals genome dynamics in Arabidopsis thaliana, Simon et al. 2018, Nucleic Acids Res. Apr 6;46(6):3019-3033

References - Customized Assays

Genetic Alterations within the DENND1A Gene in Patients with Polycystic Ovary Syndrome (PCOS), Eriksen et al. 2013, PLoS ONE 8(9), e77186

References - Custom Oligonucleotides

Prevalence and genotypes of Borrelia burgdorferi sensu lato infection in Ixodes ricinus ticks in southern Norway, Kjelland et al. 2010, Scand J Infect Dis. Aug;42(8):579-585

MDM2 facilitates adipocyte differentiation through
CRTC-mediated activation of STAT3, Hallenborg et al. 2016, Cell Death Dis. Jun 30;7(6):e2289

KRAS genotyping by digital PCR combined with melting curve analysis, Tanaka et al. 2019, Sci Rep, Feb 22;9(1):2626

Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing, Alquezar-Planas et al. 2013, Sci Rep.3:2468

References - IVD Assays

SensiScreen®KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations, Riva et al. 2017, PLoS ONE, Jun 21;12(6):e0178027

PlentiPlex™ Mastocytosis CE IVD, Kristensen et al. 2020, Allergy

PentaBase is a knowledge-based Danish pharmacogenomics company founded and managed by researchers and located in the heart of Denmark. We specialize in custom oligonucleotide production and the development of in vitro diagnostic assays for real-time PCR with a special focus on the detection of somatic mutations in cancer.

About Us
Meet the team
News
Career
Sponsorships

Book Test
COVID-19 for Companies
Antibody ELISA test

Assays & Instruments

Cancer Mutations
CoviDetect™ Assay
CoviDetect™ FAST Assay
SARS-CoV-2 Mutations
SARS-CoV-2 Oligonucleotides

© Copyright 2021 Pentabase CVR: 30197852 Petersmindevej 1A DK-5000 Odense C, Denmark

Privacy Policy
Cookie Policy